Self-Care Or Professional Help? The Role Of Symptom Severity

Published Sep 17, 2012
Aberdeen, UK – To design cost-effective health services, we need to understand how people choose to manage the symptoms they experience. Building on previous work, Lisa Rennie, Dr. Terry Porteous and Professor Mandy Ryan from the University of Aberdeen, evaluated how preferences for medical help increase as perceived severity of symptoms increase. Respondents to the survey said they preferred to self-manage minor symptoms of illnesses. To manage potentially serious symptoms, a medical practitioner was valued (in monetary terms) more than three times higher than self-care. However, in order to reduce the waiting time and cost of managing their symptoms, people were willing to compromise on which health professional they consulted. Dr. Terry Porteous comments “Although people seem to prefer self-management of minor conditions, experience tells us that many GP consultations are for symptoms that could be managed without medical intervention. Initiatives such as the pharmacy-led Minor Ailments Scheme in the UK, which supports people wishing to practise self-care, may help to reduce future GP consultations for minor conditions.” The article, “Preferences for managing symptoms of differing severity: A discrete choice experiment,” which describes the full details of the discrete choice experiment used to measure people’s preferences for symptom management, can be found in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×